ROTHSCHILD INVESTMENT LLC

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 85338 CHICAGO, IL

Position in VRTX

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$2,005,795

+$1,810,658 QoQ

Shares Held

4,038

+824.0% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.09%

of 13F equity value

Holder Rank

#677

of 1,742 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

ROTHSCHILD INVESTMENT LLC holds $12,549,080 across 228 Biotechnology names. VRTX ranks #1 (16.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma This page	4,038	$2,005,795
2	JAZZ	Jazz Pharmaceuticals plc	6,237	$1,502,929
3	CORT	Corcept Therapeutics Inc	12,195	$1,060,355
4	BMRN	Biomarin Pharmaceutical Inc	15,577	$891,315
5	ALNY	Alnylam Pharmaceuticals, Inc.	2,761	$831,143
6	RVMD	Revolution Medicines, Inc.	3,970	$743,501
7	REGN	Regeneron Pharmaceuticals, Inc.	1,168	$728,294
8	EXEL	Exelixis, Inc.	11,735	$638,501

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,005,795	4,038	+824.0%	Shares	Sole	2026-08-06
2026-03-31	$195,137	437	+12.9%	Shares	Sole	2026-05-07
2025-12-31	$175,450	387	+11.8%	Shares	Sole	2026-02-10
2025-09-30	$135,507	346	-16.2%	Shares	Sole	2025-11-07
2025-06-30	$183,867	413	+1.0%	Shares	Sole	2025-08-11
2025-03-31	$198,291	409	-37.7%	Shares	Sole	2025-04-08
2024-12-31	$264,573	657	-0.8%	Shares	Sole	2025-02-04
2024-09-30	$307,882	662	-3.5%	Shares	Sole	2024-10-18
2024-06-30	$321,541	686	+157.9%	Shares	Sole	2024-07-31
2024-03-31	$111,190	266	+10.8%	Shares	Sole	2024-07-31
2023-12-31	$97,653	240	—	Shares	Sole	2024-07-31
No filing history on record for this holder in this stock.